Surgery of the Endocrine Pancreas

  • Anthony J. Edis
  • Luis A. Ayala
  • Richard H. Egdahl
Part of the Comprehensive Manuals of Surgical Specialties book series (CMSS)


Pluripotential hormone-secreting cells belonging to the APUD cell system (see p. 132) are distributed throughout the human foregut and its endocrine derivatives [75]. Pancreatic islet cell tumors arise from this system and are capable of secreting virtually any of the known polypeptide hormones.


Total Gastrectomy Distal Pancreatectomy Serum Gastrin Endocrine Pancreas Islet Cell Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alfidi RJ, Bhyun DS, Crile G, Jr, et al: Arteriography and hypoglycemia. Surg Gynecol Obstet 133: 447, 1971.PubMedGoogle Scholar
  2. 2.
    Amberg JR, Ellison EH, Wilson SD, et al: Roentgenographic observations in the Zollinger-Ellison syndrome. JAMA 190: 185, 1964.PubMedGoogle Scholar
  3. 3.
    Aoyagi T, Summerskill WHJ: Gastric secretion with ulcerogenic islet cell tumor: Importance of basal acid output. Arch Intern Med 117: 667, 1966.PubMedGoogle Scholar
  4. 4.
    AvRuskin TW, Coran AG, Crigler JF, Jr: Insulin and growth hormone regulation in organic hyperinsulinism. Surg Gynecol Obstet 133: 1, 1971.PubMedGoogle Scholar
  5. 5.
    Ballard HS, Frame B, Hartsock RJ: Familial multiple endocrine adenoma peptic ulcer complex. Medicine 43: 481, 1964.PubMedGoogle Scholar
  6. 6.
    Barbezat GO, Grossman Ml: Intestinal secretion: Stimulation by peptides. Science 174: 422, 1971.PubMedGoogle Scholar
  7. 7.
    Baruh S, Sherman K, Kolodny HD, et al: Fasting hypoglycemia. Med Clin North Am 57: 1441, 1973.PubMedGoogle Scholar
  8. 8.
    Bell WE, Samaan NA, Longnecker DS: Hypoglycemia due to organic hyperinsulinism in infancy. Arch Neurol 23: 330, 1970.PubMedGoogle Scholar
  9. 9.
    Berson SA, Yalow RS, Bauman A, et al: Insulin 1311 metabolism in human subjects: Demonstration of insulin binding globulin in the circulation of isulin treated subjects. J Clin Invest 35: 170, 1956.PubMedGoogle Scholar
  10. 10.
    Berson SA, Yalow RS: Nature of immunoreactive gastrin extracted from tissues of gastrointestinal tract. Gastroenterology 60: 215, 1971.PubMedGoogle Scholar
  11. 11.
    Bloom SR, Polak JM, Pearse AGE: Vasoactive intestinal hormone and watery diarrhea syndrome. Lancet 2: 14, 1973.PubMedGoogle Scholar
  12. 12.
    Bonfils S, Bader JP: The diagnosis of Zollinger-Ellison syndrome with special reference to the multiple endocrine adenomas, in Progress in Gastroenterology, Vol. 2 ( GB Jersey Glass, editor). Grune and Stratton, Inc, New York, 1970, p. 332.Google Scholar
  13. 13.
    Bradley EL, III, Galambos JT: Failure of a secretin feedback loop in the ZollingerEllison syndrome? The “gastric factor” revisited. Am J Dig Dis 17: 939, 1972.PubMedGoogle Scholar
  14. 14.
    Briedahl HD, Priestley JT, Rynearson EH: Hyperinsulinism; surgical aspects and results. Ann Surg 142: 698, 1955.Google Scholar
  15. 15.
    Broder LE, Carter SK: Pancreatic islet cell carcinoma. Ann Intern Med 79: 108, 1973.PubMedGoogle Scholar
  16. 16.
    Cameron AJ, Hoffman HN: Zollinger-Ellison syndrome. Mayo Clin Proc 49: 44, 1974.PubMedGoogle Scholar
  17. 17.
    Cate11 RB, Warren KW: Surgery of the Pancreas. WB Saunders, Philadelphia, 1954.Google Scholar
  18. 18.
    Chandalia HB, Boshell BR: Hypoglycemia associated with extrapancreatic tumors. Arch Intern Med 129: 447, 1972.PubMedGoogle Scholar
  19. 19.
    Chaudhuri TK, Chaudhuri TK, Shirazi SS, et al: Radioisotopic scan-a possible aid in differentiating retained gastric antrum from Zollinger-Ellison syndrome in patients with recurrent peptic ulcer. Gastroenterology 65: 697, 1973.PubMedGoogle Scholar
  20. 20.
    Conn JW, Seltzer HS; Spontaneous hypoglycemia. Am J Med 19: 460, 1955.PubMedGoogle Scholar
  21. 21.
    Couropmitree C, Freinkel N, Nagel TC, et al: Plasma C-peptide and diagnosis of factitious hyperinsulinism. Ann Intern Med 88: 201, 1975.Google Scholar
  22. 22.
    Cowley DJ, Dymock IW, Boyes BE, et al: Zollinger-Ellison syndrome type 1: Clinical and pathological correlations in a case. Gut 14: 25, 1973.PubMedGoogle Scholar
  23. 23.
    Creutzfeldt W, Arnold R, Creutzfeldt C, et al: Pathomorphological, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Hum Pathol (in press).Google Scholar
  24. 24.
    Davenport HW: Physiology of the Digestive Tract: An Introductory Text, Third Edition. Yearbook Medical Publishers, Chicago, 1971.Google Scholar
  25. 25.
    Dent RI, James JH, Wang C-A, et al. Hyperparathyroidism: gastric acid secretion and gastrin. Ann Surg 176: 360, 1972.PubMedGoogle Scholar
  26. 26.
    dePeyster FA: Planning the appropriate operations for islet cell tumors of the pancreas. Surg Clin North Am 50: 133, 1970.PubMedGoogle Scholar
  27. 27.
    Elias E, Bloom SR, Welbourne RB, et al: Pancreatic cholera due to production of gastric inhibitory polypeptide. Lancet 2: 791, 1972.PubMedGoogle Scholar
  28. 28.
    Ellison EH, Wilson SD: Zollinger-Ellison syndrome: Reappraisal and evaluation of 260 registered cases. Ann Surg 160: 512, 1964.PubMedGoogle Scholar
  29. 29.
    Epstein HY, Abrams RM, Beranbaum ER, et al: Angiographic localization of insulinomas: High reported success rate and two additional cases. Ann Surg 169: 349, 1969.PubMedGoogle Scholar
  30. 30.
    Fajans SS, Conn JW: An intravenous tolbutamide test as an adjunct in the diagnosis of functioning pancreatic islet cell adenomas. J Lab Clin Med 54: 811, 1959.Google Scholar
  31. 31.
    Fajans SS, Floyd JC, Jr: Hypoglycemia: How to manage a complex disease. Mod Med 41: 24, 1973.Google Scholar
  32. 32.
    Fajans SS, Schneider JM, Schteingart DE, et al: Diagnostic value of tolbutamide in hypoglycemic states. J Clin Endocrinol 21: 371, 1961.Google Scholar
  33. 33.
    Ferris DO, Molnar GD, Schnelle N, et al: Recent advances in management of functioning islet cell tumor. Arch Surg 104: 443, 1972.PubMedGoogle Scholar
  34. 34.
    Filipi CJ, Higgins GA: Diagnosis and management of insulinoma. Am J Surg 125: 231, 1973.PubMedGoogle Scholar
  35. 35.
    Fonkalsrud EW, Dilley RB, Longmire WP, et al: Insulin secreting tumors of the pancreas. Ann Surg 159: 730, 1964.PubMedGoogle Scholar
  36. 36.
    Fox PS, Hofmann JW, DeCosse JJ, et al: The influence of total gastrectomy on survival in malignant Zollinger-Ellison tumors. Ann Surg (in press).Google Scholar
  37. 37.
    Fox PS, Hofmann JW, Wilson SD, et al: Surgical management of the Zollinger Ellison syndrome. Surg Clin North Am 54: 395, 1974.PubMedGoogle Scholar
  38. 38.
    Friesen SR: Effect of total gastrectomy on the Zollinger-Ellison tumor: observations by second-look procedures. Surgery 62: 609, 1967.PubMedGoogle Scholar
  39. 39.
    Friesen SR: The endocrine pancreas, in Manual of Preoperative and Postoperative Care ( JM Kinney, RH Egdahl, GD Zuidema, editors). WB Saunders Co, Philadelphia, 1971, p. 514.Google Scholar
  40. 40.
    Friesen SR, Bolinger RE, Pearse AGE, et al: Serum gastrin levels in malignant Zollinger-Ellison syndrome after total gastrectomy and hypophysectomy. Ann Surg 172: 504, 1970.PubMedGoogle Scholar
  41. 41.
    Fry WJ, Child CG: Ninety-five percent distal pancreatectomy for chronic pancreatitis. Ann Surg 162: 543, 1965.PubMedGoogle Scholar
  42. 42.
    Fulton RE, Sheedy PF, III, Mcllraith DC, et al: Preoperative angiographic localization of insulin-producing tumors of the pancreas. Am J Roentgenol Rad Ther Nucl Med 123: 367, 1975.Google Scholar
  43. 43.
    Ganguli PC, Pearse AGE, Polak JB, et al: Antral-gastrin-cell hyperplasia in peptic ulcer disease. Lancet 1: 583, 1974.PubMedGoogle Scholar
  44. 44.
    Giacobazzi P, Passaro E, Jr.: Preoperative angiography in the Zollinger-Ellison syndrome. Am J Surg 126: 74, 1973.PubMedGoogle Scholar
  45. 45.
    Go VLW, Poley JR, Hoffman AF et al: Disturbances in fat digestion induced by acidic jejunal pH due to gastric hypersecretion in man. Gastroenterology 55: 705, 1968.Google Scholar
  46. 46.
    Graham RR: quoted in G Howland, WR Campbell, EJ Maltby, et al: Dysinsulism: Convulsions and coma due to islet-cell tumor of the pancreas with operation and cure. JAMA 93:674, 1929.Google Scholar
  47. 47.
    Gray RK, Rosch J, Grollman JH, Jr: Arteriography in the diagnosis of islet-cell tumors. Radiology 97: 39, 1970.PubMedGoogle Scholar
  48. 48.
    Greider MH, Elliott DW, Zollinger RM: An electron microscopic study of islet cell adenomas. JAMA 186: 120, 1963.Google Scholar
  49. 49.
    Greider MH, McGuigan JE: Cellular localization of gastrin in the human pancreas. Diabetes 20: 389, 1971.Google Scholar
  50. 50.
    Hansky J: Antral-gastrin-cell hyperplasia in peptic ulcer disease. Lancet 1: 1344, 1974.PubMedGoogle Scholar
  51. 51.
    Harrison TS, Child CG, Fry WJ, et al: Current surgical management of functioning islet cell tumors of the pancreas. Ann Surg 178: 485, 1973.PubMedGoogle Scholar
  52. 52.
    Isenberg JI, Csendes A, Walsh JH: Resting and pentagastrin-stimulated gastroesophageal sphincter pressure in patients with Zollinger-Ellison syndrome. Gastroenterology 61: 655, 1971.PubMedGoogle Scholar
  53. 53.
    Isenberg JI, Walsh JH, Grossman MI: Zollinger-Ellison syndrome. Gastroenterology 65:140, 1973.Google Scholar
  54. 54.
    Isenberg JI, Walsh JH, Passaro E, et al: Unusual effect of secretin on serum gastrin, serum calcium, and gastric secretion in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology 62: 626, 1972.PubMedGoogle Scholar
  55. 55.
    Jaffe BM, Peskin GW, Kaplan EL: Serum levels of parathyroid hormone in the Zollinger-Ellison syndrome. Surgery 74: 621, 1973.PubMedGoogle Scholar
  56. 56.
    Keaveny TV, Tawes R, Belzer FO: A new method for intraoperative identification of insulinomas. Br J Surg 58: 233, 1971.PubMedGoogle Scholar
  57. 57.
    Korman MG, Scott DH, Hansky J, et al: Hypergastrinaemia due to an excluded gastric antrum: A proposed method of differentiation from the Zollinger-Ellison syndrome. Aust NZ J Med 3: 266, 1972.Google Scholar
  58. 58.
    Korobkin MT, Palubinskas AJ, Glickman MG: Pitfalls in arteriography of islet cell tumors of the pancreas. Radiology 100:319, 1971.Google Scholar
  59. 59.
    Koutras P, White RR: Insulin-secreting tumors of the pancreas. Surg Clin North Am 52: 299, 1972.PubMedGoogle Scholar
  60. 60.
    Kraft AR, Tompkins RK, Zollinger RM: Recognition and management of the diarrheal syndrome caused by nonbeta islet cell tumors of the pancreas. Am J Surg 119:163, 1970.Google Scholar
  61. 61.
    Lacy PE, Greider MH: Ultrastructural organization of mammalian pancreatic islets, in Handbook of Physiology,Section 7, Endocrinology,Vol. 1. American Physiological Society, Washington DC, 1972, p: 77.Google Scholar
  62. 62.
    Laroche GP, Ferris DO, Priestley JT, et al: Hyperinsulinism. Arch Surg 96: 763, 1968.PubMedGoogle Scholar
  63. 63.
    Lazaus SS, Volk BW: The Pancreas in Human and Experimental Diabetes. Grune and Stratton, New York, 1962.Google Scholar
  64. 64.
    Maingot R: Abdominal Operations, Fifth Edition. New York, Appleton-CenturyCrofts, Inc., New York, 1969, p. 452.Google Scholar
  65. 65.
    Markowitz AM, Slanetz CA, Jr, Frantz VK: Functioning islet cell tumors of the pancreas: 25-year follow-up. Ann Surg 154: 877, 1961.PubMedGoogle Scholar
  66. 66.
    Marks IN, Bank J, Louw JH: Islet cell tumor of the pancreas with reversible watery diarrhea and achlorhydria. Gastroenterology 52: 695, 1967.PubMedGoogle Scholar
  67. 67.
    Marks V, Samols E: Insulinoma: Natural history and diagnosis. Clin Gastroenterol 3:559, 1974.Google Scholar
  68. 68.
    McGuigan JE, Colwell JA, Franklin J: Effect of parathyroidectomy on hypercalcemic hypersecretory peptic ulcer disease. Gastroenterology 66: 269, 1974.PubMedGoogle Scholar
  69. 69.
    Moss NH, Rhoads JE: Hyperinsulinism and islet cell tumors of the pancreas, in Surgical Diseases of the Pancreas ( JM Howard, GL Jordon Jr., editors). JB Lippincott, Philadelphia, 1960, Chapter 21.Google Scholar
  70. 70.
    Murray-Lyon IM, Eddleston ALWF, Williams R, et al: Treatment of multiplehormone-producing malignant islet-cell tumors with streptozotocin. Lancet 2: 895, 1968.PubMedGoogle Scholar
  71. 71.
    Nardi GL: Insulinomas, in Advances in Surgery, Vol. 5. Yearbook Medical Publishers, Inc., Chicago, 1971, p. 103.Google Scholar
  72. 72.
    Oberhelman HA: Excisional therapy for ulcerogenic tumors of the duodenum: long-term results. Arch Surg 104:447, 1972.Google Scholar
  73. O’Neal LW, Kipnis DM, Luce SA, et al: Secretion of various endocrine substances by ACTH-secreting tumors: Gastrin, melanotropin, serotonin, parathormone, vasopressin, glucagon. Cancer 21:1219 1968.Google Scholar
  74. 74.
    Palumbo PJ, Molnar GD, Taylor WF, et al: Insulin antibody binding in diabetes mellitus and factitious hypoglycemia. Mayo Clin Proc 44: 725, 1969.PubMedGoogle Scholar
  75. 75.
    Pearse AGE, Polak J: Neural crest origin of the endocrine polypeptide (APUD) cells of the gastrointestinal tract and pancreas Gut 12: 783, 1971.PubMedGoogle Scholar
  76. 76.
    Polak JM, Stagg B, Pearse AGE: Two types of Zollinger-Ellison syndrome: Immunofluorescent, cytochemical, and ultrastructural studies of the antral and pancreatic gastric cells in different clinical states. Gut 13: 501, 1972.PubMedGoogle Scholar
  77. 77.
    Porter MR, Frantz VK: Tumors associated with hypoglycemia: Pancreatic and extrapancreatic. Am J Med 944: 21, 1956.Google Scholar
  78. 78.
    Priest WM, Alexander MK: Islet-cell tumor of the pancreas with peptic ulceration, diarrhea, and hypokalemia. Lancet 2: 1145, 1957.Google Scholar
  79. 79.
    Robins SL: The pancreas, in Pathology. WB Saunders, Philadelphia, 1967, p. 963.Google Scholar
  80. 80.
    Rynearson EH: Hyperinsulinism among malingerers. Med Clin North Am 31: 477, 1947.PubMedGoogle Scholar
  81. 81.
    Sanzenbacher LJ, King DR, Zollinger RM: Prognostic implications of calcium-mediated gastrin levels in the ulcerogenic syndrome. Am J Surg 125: 116, 1973.PubMedGoogle Scholar
  82. 82.
    Sanzenbacher LJ, Mekhjian HS, King DR, et al: Studies on the potential role of secretin in the islet cell tumor diarrhogenic syndrome. Ann Surg 176: 394, 1972.PubMedGoogle Scholar
  83. 83.
    Schein P, Kahn R, Gorden P, et al: Streptozotocin for malignant insulinomas and carcinoid tumors: Report of eight cases and a review of the literature. Arch Intern Med 132: 555, 1973.PubMedGoogle Scholar
  84. 84.
    Schnelle N, Molnar GD, Ferris DO, et al: Circulating glucose and insulin in surgery for insulinomas. JAMA 217: 1072, 1971.PubMedGoogle Scholar
  85. 85.
    Service FJ, Palumbo PJ: Facticial hypoglycemia: Three cases diagnosed on the basis of insulin antibodies. Arch Intern Med 134: 336, 1974.PubMedGoogle Scholar
  86. 86.
    Shatney CH, Grage TB: Diagnostic and surgical aspects of insulinoma. Am J Surg 127: 174, 1974.PubMedGoogle Scholar
  87. 87.
    Sherman BM, Pek S, Fajans SS, et al: Plasma proinsulin in patients with functioning islet cell tumors. J Clin Endocrinol Metab 35: 271, 1972.PubMedGoogle Scholar
  88. 88.
    Silen W: Pancreas, in Principles of Surgery ( SI Schwartz, editor). McGraw Hill Book Co, New York, 1969, p. 1112.Google Scholar
  89. 89.
    Sircus W: Peptide-secreting tumors and peptic ulcer. Clin Gastroenterol 2: 447, 1973.Google Scholar
  90. 90.
    Spiro EM: Clinical Gastroenterology. The MacMillan Co, Toronto, 1970.Google Scholar
  91. 91.
    Stadil F, Rehfeld JF, Thaysen EH: Gastric juice as gastric-releasing factor in the Zollinger-Ellison syndrome. Lancet 2: 102, 1971.PubMedGoogle Scholar
  92. 92.
    Stefanini P, Carboni M, Patrassi N, et al: Beta-islet cell tumors of the pancreas: Results of a study on 1,067 cases. Surgery 75: 597, 1974.PubMedGoogle Scholar
  93. 93.
    Stefanini P, Carboni M, Patrassi N: Surgical treatment and prognosis of insulinoma. Clin Gastroenterol 3: 697, 1974.Google Scholar
  94. 94.
    Thompson JC, Reeder DD, Bunchman H H: Clinical role of serum gastrin measurements in the Zollinger-Ellison syndrome. Am J Surg 124: 250, 1972.PubMedGoogle Scholar
  95. 95.
    Thompson S, Welch KJ: Surgery of the pancreas, in Pediatric Surgery ( CD Benson, MM Mustard, WH Snyder Jr, et al, editors). Yearbook Medical Publishers, Inc, 1962, p. 629.Google Scholar
  96. 96.
    Turbey WJ, Passaro EW, Jr: Hyperparathyroidism in the Zollinger-Ellison syndrome. Arch Surg 105: 62, 1972.PubMedGoogle Scholar
  97. 97.
    Turner RC, Johnson PC: Suppression of insulin release by fish-insulin-induced hypoglycemia with reference to the diagnosis of insulinomas. Lancet Vol. 1: 1483, 1973.Google Scholar
  98. 98.
    Verner JV, Morrison AB: Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 29: 529, 1958.Google Scholar
  99. 99.
    Walsh JH, Grossman MI: Gastrin. IV Engl J Med 292: 1377, 1975.Google Scholar
  100. 100.
    Warren KW: Current management of benign and malignant pancreatic tumors. Am Surg 20: 1070, 1954.PubMedGoogle Scholar
  101. 101.
    Wermer P: Genetic aspects of adenomatosis of endocrine glands. Am J Med 16: 363, 1954.PubMedGoogle Scholar
  102. 102.
    Whipple AO: Hyperinsulinism in relation to pancreatic tumors. Surgery 16: 289, 1944.Google Scholar
  103. 103.
    Whipple AO, Frantz VK: Adenoma of islet cells with hyperinsulinism. Ann Surg 101: 1299, 1935.PubMedGoogle Scholar
  104. 104.
    Wilder RM, Allan FH, Power MH, et al: Carcinoma of the islands of the pancreas. Hyperinsulinism and hypoglycemia. JAMA 89: 348, 1927.Google Scholar
  105. 105.
    Wilson SD, Ellison EH: Survival in patients with the Zollinger-Ellison syndrome treated by total gastrectomy. Am J Surg 111: 787, 1966.PubMedGoogle Scholar
  106. 106.
    Winship DH: Patterns in the diagnosis of Zollinger-Ellison syndrome by analysis of gastric secretion, non-insulin-producing tumors of the pancreas, in Modern Aspects on Zollinger-Ellison Syndrome and Gastrin. (L Demling, R Ottenjann, editors). International Symposium at Erlangen, July 16–17, 1968. Georg Thieme Verlag, Stuttgart, 1969, p. 129.Google Scholar
  107. 107.
    Winship DH, Ellison EH: Variability of gastric secretion in patients with and without Zollinger-Ellison syndrome. Lancet 1: 1128, 1967.PubMedGoogle Scholar
  108. 108.
    Wright HK, Hersh T, Floch MH, et al: Impaired intestinal absorption in the Zollinger-Ellison syndrome independent of gastric hypersecretion. Am J Surg 119: 250, 1970.PubMedGoogle Scholar
  109. 109.
    Zollinger RM: Islet cell tumor of the pancreas and the alimentary tract. Am J Surg 129: 102, 1975.PubMedGoogle Scholar
  110. 110.
    Zollinger RM, Ellison EH: Primary hepatic ulceration of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142: 709, 1955.PubMedGoogle Scholar
  111. 111.
    Zollinger RM, Tompkins RK, Amerson JR, et al: Identification of the diarrheogenic hormone associated with nonbeta islet cell tumors of the pancreas. Ann Surg 168:502, 1968.Google Scholar

Copyright information

© Springer Science+Business Media New York 1975

Authors and Affiliations

  • Anthony J. Edis
    • 1
  • Luis A. Ayala
    • 2
  • Richard H. Egdahl
    • 3
  1. 1.Department of SurgeryMayo ClinicRochesterUSA
  2. 2.Centro Médico de CaracasPlaza El EstanqueSan Bernardino, Caracas 101Venezuela
  3. 3.Boston University Medical CenterBostonUSA

Personalised recommendations